drug

vorasidenib citrate

Marketedupdated 2mo ago

by Les Laboratoires Servier SAS

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Aug 6, 2029

~3.1 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (10)

Jan 16, 2039compositionUS 11345677
Jan 16, 2039compositionUS 11345677
Dec 4, 2035method-of-use (U-3977)US 11844758
Dec 4, 2035method-of-use (U-3977)US 11844758
Jul 11, 2034compositionUS 10172864
Jul 11, 2034compositionUS 10172864
Jul 11, 2034method-of-use (U-4286)US 12433895
Jul 11, 2034method-of-use (U-4286)US 12433895
Jul 11, 2034compositionUS 9579324
Jul 11, 2034compositionUS 9579324

FDA exclusivities (4)

Aug 6, 2031ODE-491Orphan Drug (7y)
Aug 6, 2031ODE-491Orphan Drug (7y)
Aug 6, 2029NCENew Chemical Entity (5y)3.1y
Aug 6, 2029NCENew Chemical Entity (5y)3.1y